These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14573658)

  • 1. DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein.
    Simon BE; Cornell KA; Clark TR; Chou S; Rosen HR; Barry RA
    Infect Immun; 2003 Nov; 71(11):6372-80. PubMed ID: 14573658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
    Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
    Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
    J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.
    Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ
    Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.
    Ratnoglik SL; Jiang DP; Aoki C; Sudarmono P; Shoji I; Deng L; Hotta H
    PLoS One; 2014; 9(6):e98877. PubMed ID: 24901478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.
    Wedemeyer H; Gagneten S; Davis A; Bartenschlager R; Feinstone S; Rehermann B
    Gastroenterology; 2001 Nov; 121(5):1158-66. PubMed ID: 11677208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
    Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
    Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.
    Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G
    J Gen Virol; 2002 Feb; 83(Pt 2):369-381. PubMed ID: 11807230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].
    Lang Kuhs KA; Ginsberg AA; Yan J; Wiseman RW; Khan AS; Sardesai NY; O'Connor DH; Weiner DB
    Mol Ther; 2012 Mar; 20(3):669-78. PubMed ID: 21952169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
    Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
    J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse.
    Eisenbach C; Freyse A; Lupu CM; Weigand K; Ernst E; Hoyler B; Stremmel W; Bugert JJ; Encke J
    Vaccine; 2006 Jun; 24(24):5140-8. PubMed ID: 16713033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Levander S; Sällberg M; Ahlén G; Frelin L
    Vaccine; 2016 May; 34(25):2821-33. PubMed ID: 27109565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.